Skip to main content

Advertisement

SpringerLink
Log in

Controversy regarding gastric cancer and diabetes

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

The Original Article was published on 23 April 2015

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sekikawa A, Fukui H, et al. Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol. 2015. doi:10.1007/s00535-015-1081-0.

  2. Inoue M, Iwasaki M, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166(17):1871–7.

    Article  PubMed  Google Scholar 

  3. Khan M, Mori M, et al. Japan Collaborative Cohort Study Group. site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev. 2006;7(2):253–9.

    PubMed  Google Scholar 

  4. Hidaka A, Sasazuki S, JPHC Study Group, et al. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer. 2015;136(6):1402–10.

    Article  PubMed  CAS  Google Scholar 

  5. Kasuga M, Ueki K, et al. Report of the Japan Diabetes Society/Japanese Cancer Association joint committee on diabetes and cancer. Cancer Sci. 2013;104(7):965–76.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Diabetes and Metabolic Diseases, Nihon University School of Medicine, Tokyo, Japan

    Midori Fujishiro & Hisamitsu Ishihara

Authors
  1. Midori Fujishiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisamitsu Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Midori Fujishiro.

Ethics declarations

Conflict of interest

Hisamitsu Ishihara has received lecture fees from Asteras, Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo Inc., Eli Lilly and Company, Kowa Pharmaceutical Co., MSD, Novartis Pharmaceuticals, Novo Nordisk Pharma, Ono Pharmaceutical Co., Mitsubishi Tanabe Pharma, and Sanofi, and research funds from Asteras, Boehringer Ingelheim, Daiichi Sankyo Inc., Eli Lilly, Kowa Pharmaceutical Co., MSD, Mitsubishi Tanabe Pharma, Novartis Pharmaceuticals, Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical Co.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujishiro, M., Ishihara, H. Controversy regarding gastric cancer and diabetes. J Gastroenterol 51, 80–81 (2016). https://doi.org/10.1007/s00535-015-1113-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-015-1113-9

Keywords

Search

Navigation